Sustanon 250

Quick links to important sections

Sustanon 250

Selected form

Method of action: Anabolic, Androgenic

Treatment option:

Medically reviewed

Laura Arias

Last updated on 22/12/2025

This page provides general, reference-level information compiled from official medical sources. It is not a substitute for professional medical advice, diagnosis, or treatment. For decisions about your health, please consult a qualified healthcare professional.

Overview of Sustanon 250

What is Sustanon 250? Defining the Androgen Class

Property Description
Active ingredient Four testosterone esters blend
Form Solution for intramuscular injection
Pharmacological class Androgen, Anabolic Steroid
General purpose Hormone replacement therapy (TRT)
Origin Chemically derived (synthetic esters of natural hormone)

Sustanon 250 is a specific Prescription Only Medicine classified primarily as an androgen and, more broadly, an anabolic steroid, functioning as an exogenous source for testosterone replacement therapy (TRT). It is a specialized, injectable pharmaceutical preparation used to supplement or substitute the natural testosterone produced by the body. This drug entity belongs to the pharmacological group of Androgens, with the official ATC code G03B A03.

Composition: The Unique Blend of Four Testosterone Esters

Sustanon 250 is fundamentally an oil-based solution for intramuscular injection containing a unique blend of four chemically distinct testosterone esters. The active components, all esters of the natural hormone testosterone, include 30 mg of Testosterone Propionate, 60 mg of Testosterone Phenylpropionate, 60 mg of Testosterone Isocaproate, and 100 mg of Testosterone Decanoate. This specific blending of short- to long-acting esters is a distinctive feature of the Sustanon formulation, designed for the purpose of prolonging hormone action. The blend ensures the medication is long-acting, achieving a stable, therapeutic level of testosterone in the plasma over an extended period following administration.

General Purpose of Sustained Hormone Restoration

The general purpose of Sustanon 250 is to provide continuous, stable levels of testosterone to correct a confirmed hormone deficit, such as that associated with male hypogonadism. The sustained release achieved by the four-ester composition allows the released testosterone to effectively stimulate necessary physiological processes, including the maintenance of anabolic effects—such as muscle mass and bone density—alongside supporting overall vitality and structural well-being. Testosterone replacement helps maintain secondary male sex characteristics and support normal function in deficient individuals. By restoring these hormone levels, the medication aims to correct the systemic dysfunction resulting from insufficient androgen presence in the body.

Regulatory References

  1. NIH, Prolonging Testosterone Action
  2. NIH, MedlinePlus

What side effects are possible with Sustanon 250?

Possible Side Effects and Safety Information

Adverse reactions associated with testosterone ester preparations like Sustanon 250 are officially categorized by frequency and the body system affected, according to regulatory documents.


Classification of Adverse Reactions

Adverse reactions are grouped by System-Organ Class (SOC), with documented effects spanning the Blood and Lymphatic System, Metabolic, Psychiatric, Vascular, Skin, and Reproductive systems.

Frequency Examples of Documented Adverse Reactions
Common (Up to 1 in 10) Polycythaemia (increased red blood cell count), weight gain, hypertension, increased Prostate Specific Antigen (PSA) levels, and gynecomastia.
Uncommon (Up to 1 in 100) Depression, nervousness, hostility, headache, nausea, acne, myalgia, and testicular atrophy.

Serious Safety Considerations

Regulatory documents emphasize specific risks. Venous Thromboembolism (VTE), including Deep Vein Thrombosis (DVT) and Pulmonary Embolism (PE), is a known safety concern. Testosterone is contraindicated in men with known or suspected prostate cancer or male breast cancer. Caution is required in patients with severe pre-existing cardiac, renal, or hepatic disease due to the risk of fluid retention leading to severe oedema.

Population and Duration Notes

For pediatric use, testosterone poses a risk of premature epiphyseal closure (growth limitation). Older adults require closer monitoring for prostate issues and polycythaemia. An excessive frequency or duration of erections (Priapism) is cited as a sign of overdosage, and the risk of prostate changes is linked to long-term exposure.

Overdose and Emergency Response

Overdose and when to seek help — official regulatory information for Sustanon 250

Feature Official Regulatory Statement
Documented overdose presentations Symptoms of chronic overdosage include priapism (prolonged, painful, or frequent erections) and polycythaemia (increase in red blood cell count). These are the officially documented clinical manifestations of overexposure.
Dose-related or exposure-related factors The official documentation states that the acute intramuscular toxicity of the medicine is very low and that acute overdosage is generally not a medical emergency. The observed clinical effects are related to chronic overexposure.
Emergency-response statements The mandated response for chronic overdosage is to discontinue treatment immediately. Following the disappearance of symptoms, treatment may be resumed at a lower dosage. Overdosage treatment is officially defined as symptomatic.
When immediate medical help is required Patients are instructed to talk to their doctor or nurse immediately if they experience symptoms of overdose or if they believe the medicine’s effect is too strong.

Connection to the overall overdose profile: Regulatory documents define the Sustanon 250 overdose profile by focusing on clinical signs of chronic hyperandrogenism, specifically priapism and polycythaemia, due to the substance's low acute toxicity. The required official action mandates immediate consultation with a healthcare professional to initiate treatment discontinuation and physiological monitoring, such as for red blood cell changes. This official classification confirms that the primary concern is managing prolonged overexposure, not an acute life-threatening event.

Therapeutic Uses of Sustanon 250

What Sustanon 250 Treats: Main Uses and Benefits

Sustanon 250 is a specific testosterone preparation commonly used for male hypogonadism when the deficiency has been confirmed by clinical features and biochemical tests. It is generally applied across domains where additional symptomatic support is needed in cases of low testosterone levels.


Enhancing Physical and Sexual Health

This medication is commonly used to help with symptom clusters that interfere with daily functioning, specifically addressing issues like impotence and low libido. It provides support that assists with maintaining functional stability in sexual health, and supports physical well-being by assisting with muscle maintenance.

Improving Energy and Mood Stability

Sustanon 250 is relevant in contexts marked by increased discomfort or tension, such as chronic fatigue and depressive mood associated with the deficiency. It may assist with easing the overall symptom load and helps maintain a sense of stability when symptoms are more noticeable, supporting general well-being during symptomatic phases.

Quick Fact: Focus on Low Libido Symptoms Sustanon 250 is applied in addressing sexual health symptoms associated with low androgen levels.

Supporting Bone and Physical Comfort

It is applied across domains where additional symptomatic support is needed in conditions presenting with systemic or localized discomfort, relevant in conditions characterized by periods of heightened symptoms, such as osteoporosis when linked to androgen deficiency. This supportive relief may assist with maintaining functional stability and help ease physical discomfort.

The therapeutic areas often covered include supportive relief for symptoms such as low libido, impotence, fatigue, depressive mood, and osteoporosis when linked to androgen deficiency.

Regulatory References

  1. European Medicines Agency (EMA) guidance on testosterone-containing medicines

Eligibility and Restrictions for Use

The eligibility profile for Sustanon 250 is strictly defined by official regulatory bodies, establishing clear contraindications and use restrictions based on hormone sensitivity and patient status.

Absolute Contraindications

Use is strictly prohibited in patients with known or suspected prostate or breast carcinoma. It is also contraindicated for all pregnant and breastfeeding women. Absolute non-eligibility extends to individuals with a known allergy to peanut oil or soya and to children under three years old due to a specific excipient (benzyl alcohol).

Restricted and Conditional Use

Use requires extra supervision and caution in patients with severe cardiac, hepatic, or renal insufficiency. In these populations, treatment must be stopped immediately if complications such as oedema (fluid retention) or congestive heart failure occur. Close monitoring is also mandated for patients with diabetes mellitus, epilepsy, or a history of hypertension.

Age and Data Limitations

Safety and efficacy have not been adequately determined in children and adolescents in general. Extra supervision is mandatory for pre-pubertal children to monitor for risks like accelerated sexual development and limited growth. Experience regarding safety and efficacy in patients over 65 years of age is also officially noted as limited.

What should I know about interactions with other medicines?

Interactions with other medicines and products

Sustanon 250 (testosterone ester combination) may interact with certain medicines, potentially requiring close monitoring and dose adjustment by a healthcare provider.

Medicinal Product Category Mechanism and Recommendation
Anti-diabetic Medicines (e.g., Insulin) Testosterone may improve glucose tolerance and reduce the need for anti-diabetic medicines. Blood glucose levels must be monitored carefully, especially when treatment begins or ends.
Anti-coagulants (e.g., Coumarin-type agents) Androgens can enhance the effects of these blood thinners, increasing the risk of bleeding. The dosage of the anticoagulant may need to be reduced, and prothrombin time must be closely monitored.
Corticosteroids or ACTH Concurrent use may enhance the risk of oedema (fluid retention). This combination should be used with caution, particularly in patients with pre-existing heart or liver conditions.
Enzyme Inducers/Inhibitors Medications that affect liver enzymes (Cytochrome P450) can change blood levels of testosterone. Enzyme inducers may decrease testosterone levels, while inhibitors may increase them, possibly requiring a Sustanon 250 dose adjustment.
Cyclosporins The combination may increase the risk of toxicity to the kidneys (nephrotoxicity).

Sustanon 250 may also interfere with the results of certain laboratory tests, such as those for glucose tolerance and thyroid function, and it may affect levels of clotting factors. Patients should inform all healthcare professionals that they are using this product before any new medicine is prescribed or laboratory test is conducted.

Mechanism of Action

Sustanon 250 contains four distinct testosterone esters that are designed to produce a sustained release profile. Following administration, plasma and tissue esterase enzymes hydrolyze the ester chains, progressively cleaving them to release the parent hormone, testosterone, into the systemic circulation. The half-life of release is dictated by the varying lipophilicity of the propionate, phenylpropionate, isocaproate, and decanoate moieties. The resulting free testosterone acts as an agonist for the androgen receptor (AR), a nuclear receptor protein found in target tissues such as muscle, bone, and adipose cells.

Testosterone, or its 5alpha-reduced metabolite dihydrotestosterone (DHT), binds to the AR's ligand-binding domain. This binding event initiates a conformational change and subsequent nuclear translocation of the receptor complex. Inside the nucleus, the hormone-receptor complex functions as a transcription factor, binding to specific DNA sequences known as Androgen Response Elements (AREs). This interaction modulates the rate of gene transcription, altering messenger RNA production and ultimately driving the synthesis of key proteins involved in the body's anabolic and androgenic processes.

Dosage and Administration Information

Official Instructions for Sustanon 250 Use

Sustanon 250 is an oil-based solution that must be administered strictly according to established guidelines. The instructions govern the administration method, dosing schedule, and required monitoring to ensure correct usage.

Administration Method and Schedule

This medicine must be given only by a doctor or a nurse. The required route of administration is deep intramuscular injection, typically into a large muscle such as the buttock, upper leg, or upper arm. The contents of the ampoule or vial are for a single injection only.

The standard starting dosing schedule is one injection of 1 milliliter (mL) every three weeks. This three-week frequency is generally considered adequate, but the doctor may adjust the dosage individually based on the patient's specific needs and clinical response.

Procedural Requirements and Monitoring

Correct use requires the physician to perform regular blood tests to check testosterone levels and confirm the dose is maintaining the desired therapeutic range. These tests are necessary for dose adjustment and ensuring the treatment remains within clinical protocol.

For age-specific administration, the safety and efficacy of this medicine have not been fully established in children and adolescents. Administration to children under the age of three years is contraindicated. In pre-pubertal children, statural growth and sexual development must be carefully monitored by a healthcare professional.

If a dose is missed, the patient must contact their doctor or nurse immediately to determine when the next injection should be given. A double dose must not be taken to compensate for a forgotten one.

Recent Clinical Evidence

Testosterone Replacement Therapy (TRT) Evidence

Sustanon 250 is a blend of four testosterone esters: testosterone propionate, testosterone phenylpropionate, testosterone isocaproate, and testosterone decanoate. This combination is designed to provide both a prompt initial increase in serum testosterone levels and a sustained release over time. Its primary authorized use is in Testosterone Replacement Therapy for confirmed male hypogonadism (testosterone deficiency).

Clinical trials focusing on Sustanon 250 specifically have evaluated its role in improving various aspects of health associated with low testosterone. Research has shown that, when administered to hypogonadal men, Sustanon 250 treatment can lead to improvements in sexual function, mood, and muscle mass, generally assessed over periods of several months.

Pharmacokinetics and Dosing

The formulation's differing ester chain lengths result in a staggered release pattern. Following a single intramuscular injection, total plasma testosterone levels reach peak concentrations approximately 24–48 hours after administration and typically return to the lower limit of the normal range for males in about 21 days. This extended release profile often allows for a less frequent injection schedule compared to single-ester formulations.

Ester Component Half-Life (General Profile) Release Rate
Propionate Short Rapid
Phenylpropionate Medium-Short Moderate
Isocaproate Medium-Long Sustained
Decanoate Long Very Sustained

Safety and Monitoring

Safety studies emphasize that testosterone replacement may enhance the action of coumarin anticoagulants, necessitating close INR monitoring in patients using both. Caution is also advised regarding patients with pre-existing conditions like heart failure, hypertension, or sleep apnea, as well as monitoring for potential side effects such as polycythemia (increased red blood cell count), which is checked via routine blood tests.

Frequently Asked Questions (FAQ)

Common questions about Sustanon 250 (FAQ)

Q: How quickly can someone generally expect to notice effects after starting Sustanon 250?

Official documents describe that after an injection, testosterone levels in the blood peak within approximately 24 to 48 hours. However, the clinically measurable effects on symptoms, such as improvements in mood or sexual function, are typically assessed by a healthcare provider over a period of several months of ongoing treatment.

Q: Is Sustanon 250 used for conditions other than just low testosterone?

The primary approved use of Sustanon 250 across regulatory bodies is for Testosterone Replacement Therapy for confirmed male hypogonadism (testosterone deficiency). Depending on the specific national label, some documents also include related uses such as treating osteoporosis associated with androgen deficiency or certain forms of infertility linked to sperm production disorders.

Q: Does Sustanon 250 have to be given as a shot, or are there other forms?

Sustanon 250 is formulated only as a solution for deep intramuscular injection. It is not available in other forms like tablets, gels, or patches. If other forms of testosterone are discussed, they refer to different medicines and are not the Sustanon 250 product.

Q: Is the duration of effect different for Sustanon 250 compared to single-ester testosterone?

Yes. Sustanon 250 contains a blend of four different testosterone esters, a design choice intended to provide a sustained release of the hormone over time. This extended profile generally allows for a less frequent injection schedule compared to single-ester testosterone injections.

Q: Are there specific lifestyle changes that might affect how Sustanon 250 works?

Official regulatory documents specifically note that this medicine affects glucose tolerance. Regulatory information indicates that if an individual has diabetes, close monitoring of anti-diabetic medicine dosages may be needed. Its classification as an anabolic steroid also means its use is subject to restrictions by sports authorities like the World Anti-Doping Agency (WADA).

Q: Can Sustanon 250 be used by women for any approved medical reasons?

Regulatory documents generally state that Sustanon 250 is intended for use by men only. It is specifically contraindicated (strictly prohibited) in women who are pregnant or breastfeeding, and its use in women is not listed among its official approved medical uses.

Q: If I miss an appointment for my Sustanon 250 shot, what generally happens?

Official instructions state that if an injection is missed, the patient should contact the doctor or nurse immediately to determine when the next dose should be scheduled. It is explicitly stated that a double dose must not be taken to compensate for a forgotten one.

Q: Are there any food or drink interactions listed for Sustanon 250?

Because Sustanon 250 is administered as an intramuscular injection, regulatory information states that significant interactions with food or drinks are not likely. It can be administered without taking meals or beverages into consideration.

Q: What's the difference between using Sustanon 250 and testosterone gel?

Sustanon 250 is an injection typically given every three weeks to provide a sustained release of the hormone. In contrast, testosterone gels are a topical form of hormone replacement that must be applied to the skin daily to achieve and maintain therapeutic levels.

Q: Can people who have certain heart conditions use Sustanon 250?

Patients with certain severe conditions, such as severe cardiac insufficiency (heart failure), require close supervision from a healthcare provider. Regulatory documents warn that treatment should be reviewed or stopped by a healthcare professional if severe complications like fluid retention (oedema) occur.

Q: How is the effectiveness of Sustanon 250 generally measured by doctors?

Effectiveness is generally measured through two main methods. Doctors will monitor the patient's testosterone level using regular blood tests to ensure it remains within the desired therapeutic range. They will also assess the clinical response, which means checking for an improvement in symptoms associated with low testosterone.

Q: Is there an age limit for starting treatment with Sustanon 250?

The medicine is contraindicated (prohibited) for children under three years old due to a specific inactive ingredient. While there is no defined upper age limit, regulatory documents note that experience and data are limited for patients over 65 years of age, and this group requires closer monitoring.

Q: Do studies suggest any specific long-term safety themes associated with Sustanon 250?

Official guidance emphasizes that individuals receiving long-term androgen therapy require regular monitoring by their physician. This monitoring includes checking prostate health and checking for high levels of red blood cells (polycythaemia). An increased risk of prostate changes is linked to long-term exposure.

Q: Are there any common skin reactions at the injection site for Sustanon 250?

Official patient information documents list general skin issues such as acne as an uncommon side effect. Some regulatory documents also specifically list local reactions at the injection site, such as pain at the injection site and itching.

Q: Why is Sustanon 250 sometimes associated with bodybuilding online, even though it's a prescription medicine?

Regulatory documents explicitly state that Sustanon 250 should not be used to enhance ability in sports performance as it carries serious health risks. It is classified as an anabolic steroid, which is sometimes misused for non-medical reasons, but its sole authorized purpose is treating medical testosterone deficiency.

Q: What is the role of the oil carrier in the Sustanon 250 injection?

Sustanon 250 is formulated as an oil-based solution (containing arachis/peanut oil). The oil acts as a carrier or base, which allows the testosterone esters to be released very slowly from the muscle over a period of weeks, providing the sustained effect.

Q: What research exists about the use of Sustanon 250 in older adults?

Regulatory documents state that experience regarding safety and efficacy in patients over 65 years of age is limited. This means the available research may not fully cover the entire older adult population, and therefore this age group requires closer monitoring for potential side effects such as prostate changes and high red blood cell counts.

Q: Does the package insert include information on what to do about common side effects?

Yes, package inserts advise that if androgen-associated adverse reactions occur, regulatory documents state that treatment with Sustanon 250 may be discontinued. Upon the resolution of the symptoms, treatment may be resumed at a lower dose only under the direction of a healthcare professional.

Q: Why is the drug named Sustanon 250?

The name reflects its unique formulation. Sustanon refers to its mechanism, which uses a blend of esters to provide a sustained release of the hormone. The number 250 refers to the total active content of 250 mg of testosterone esters contained in each milliliter.

Q: Is Sustanon 250 considered a cure for low testosterone, or just a management treatment?

Sustanon 250 is formally classified as a form of Testosterone Replacement Therapy (TRT). This means it is a management treatment used to supplement the natural hormone and correct the systemic effects of the deficiency, not a cure for the underlying cause of low testosterone.

Q: Why do some people experience nausea after a dose of Sustanon 250?

Official regulatory documents list nausea as an uncommon documented adverse reaction. While the occurrence is noted, the exact physiological mechanism for why this side effect may happen in some people is not explained in the patient information or prescribing documents.

Q: Is there evidence that Sustanon 250 affects bone density?

Regulatory documents note that the general purpose of testosterone replacement is to maintain anabolic effects, including supporting bone density. Clinical summaries indicate its role is to help correct systemic dysfunction from insufficient androgen presence, which includes supporting the maintenance of bone health.

Q: Can Sustanon 250 be given by someone who isn't a medical professional in some countries?

Official instructions in authorized countries state the medicine must be given only by a doctor or a nurse. This indicates that self-administration or administration by an untrained person is not the authorized and recommended method of use.

Q: Is Sustanon 250 used to treat delayed puberty in males?

Sustanon 250 is not officially licensed for use in children for delayed puberty; its official licence is for adult hypogonadism. However, it is cited in specialist medical guidelines as an established therapy used by specialists to induce puberty in specific cases under close medical supervision.

Q: What are the known drug classes that have important interactions with Sustanon 250?

Official documents list several important interacting drug classes. These include Anti-diabetic Medicines (like Insulin), Anti-coagulants (blood thinners), Corticosteroids (steroid medicines), and certain medicines that affect liver enzymes (Cytochrome P450 inducers/inhibitors).

Q: Does Sustanon 250 affect blood pressure?

Yes, official documents explicitly list hypertension (high blood pressure) as a common documented adverse reaction. Because of this, caution and close monitoring are advised for patients who have pre-existing hypertension or heart conditions.

Q: Is there any information on Sustanon 250's effect on cholesterol levels?

Yes, official documents state that in patients receiving long-term androgen therapy, the lipid profile (cholesterol levels) should be monitored regularly by a doctor. Some regulatory documents also list changes in cholesterol levels as a potential side effect.

Q: How long does the testosterone level remain elevated after a Sustanon 250 injection?

Due to its combination of esters, the formulation is designed to provide a sustained release. Total testosterone levels in the blood typically remain elevated and return to the lower limit of the normal range for males in about 21 days, which aligns with the standard dosing schedule.

Q: Does official research cover the use of Sustanon 250 in adolescents?

Official regulatory documents state that the safety and efficacy of the medicine have not been adequately determined in children and adolescents. While specialists may use it in specific cases, this general limitation means close supervision is mandatory for pre-pubertal children to monitor their growth and sexual development.

Q: Are there any risks specifically related to the injection process itself?

The injection must be administered using a deep intramuscular technique by a trained professional. In rare cases, the oily solution may accidentally enter a small blood vessel during injection, causing a pulmonary micro-embolism. This may lead to temporary symptoms such as a cough, difficulty breathing, or excessive sweating.

How should Sustanon 250 be stored and disposed of?

How to Store and Dispose of Sustanon 250?

Strict regulatory guidelines define how this medication must be stored and disposed of to ensure its stability and safety.


Official Storage Requirements

Sustanon 250 should be stored at temperatures below 30 C. It is critical not to refrigerate or freeze the product, as this may make the injection difficult. To protect the solution from environmental degradation, it must be kept in its original package to shield it from light. As a mandated safety precaution, the medicine must be stored out of the sight and reach of children in a safe place. Due to the single-use nature of the ampoule, it must be used immediately once opened.


Disposal Instructions

Unused or expired product should not be disposed of via household waste or wastewater. To ensure appropriate disposal, any unused medicine should be returned to a pharmacist or disposed of in accordance with local environmental regulations.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Available in countries:

Equivalent of Sustanon 250 found in:

A-Z Index: